Benitec Biopharma Inc.
BNTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001808898
No open-market purchases or sales by Benitec Biopharma Inc. insiders were filed in the last 90 days; 86 institutions reported holding it in 13F filings for Q2 2026, worth $443.3M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Benitec Biopharma Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- +3 vs. Q1 2021
- Shares held
- 1.52M
- +1.16M (+322.9%) vs. Q1 2021
- Total value
- $6.46M
- +$4.62M (+251.4%) vs. Q1 2021
- New holders
- 8
- 3 more added
- Sold out
- 5
- 4 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BNTC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 86 | $443.3M |
| Q1 2026 | 88 | $346.0M |
| Q4 2025 | 72 | $426.6M |
| Q3 2025 | 56 | $324.7M |
| Q2 2025 | 57 | $265.3M |
| Q1 2025 | 37 | $290.1M |
| Q4 2024 | 30 | $240.2M |
| Q3 2024 | 25 | $126.8M |
| Q2 2024 | 19 | $44.3M |
| Q1 2024 | 13 | $6.58M |
| Q4 2023 | 13 | $3.88M |
| Q3 2023 | 12 | $3.84M |
| Q2 2023 | 17 | $2.45M |
| Q1 2023 | 21 | $2.44M |
| Q4 2022 | 25 | $2.09M |
| Q3 2022 | 25 | $5.92M |
| Q2 2022 | 22 | $1.55M |
| Q1 2022 | 21 | $2.60M |
| Q4 2021 | 17 | $4.16M |
| Q3 2021 | 19 | $5.43M |
| Q2 2021 | 18 | $6.46M |
| Q1 2021 | 15 | $1.84M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Benitec Biopharma Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 48 | $0 | 0.00% | +20+71.4% | Added |
| Advisory Services Network, LLC | 3 | $0 | 0.00% | +3 | New |
| Brewin Dolphin Ltd | 6 | $26 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 304 | $1.00K | 0.00% | −1,147−79.0% | Reduced |
| Rockefeller Capital Management L.P. | 300 | $1.00K | 0.00% | 00.0% | Unchanged |
| Susquehanna Fundamental Investments, LLC | 10,760 | $46.0K | 0.00% | −40−0.4% | Reduced |
| Northern Trust Corp | 11,813 | $50.0K | 0.00% | +11,813 | New |
| WealthTrust Axiom LLC | 12,950 | $55.0K | 0.02% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 14,932 | $63.0K | 0.00% | −2,721−15.4% | Reduced |
| Private Wealth Advisors | 15,043 | $64.0K | 0.02% | +15,043 | New |
| Citadel Advisors LLC | 20,424 | $87.0K | 0.00% | −2,829−12.2% | Reduced |
| State Street Corp | 21,000 | $89.0K | 0.00% | +21,000 | New |
| BlackRock Inc. | 23,896 | $101.0K | 0.00% | +23,896 | New |
| Geode Capital Management, LLC | 34,493 | $146.0K | 0.00% | +5,933+20.8% | Added |
| Renaissance Technologies LLC | 42,700 | $181.0K | 0.00% | +42,700 | New |
| Vanguard Group Inc | 74,773 | $318.0K | 0.00% | +22,579+43.3% | Added |
| Silverarc Capital Management, LLC | 467,256 | $1.99M | 1.05% | +467,256 | New |
| Suvretta Capital Management, LLC | 769,000 | $3.27M | 0.05% | +769,000 | New |
| HighPoint Advisor Group LLC | 0 | $0 | 0.00% | −93,000−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −84,725−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −22,520−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −11,800−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −129−100.0% | Sold out |